Strategic partnerships Leverage Celera's recent collaboration with AURA and interest in expanding diagnostic software capabilities to propose joint development or integration opportunities with your sequencing, data analytics, or cloud-based health platforms.

Cardio diagnostics expansion With Berkeley HeartLab focused on cardiovascular risk tests, present complementary cardiac imaging, wearable biosensors, or lipidomics services to broaden risk assessment portfolios and cross-sell to existing BHL clients.

Laboratory services growth Celera operates both products and services. Target lab automation, sample processing throughput, and quality management solutions that enhance diagnostic test manufacturing and service efficiency for cost-conscious health systems.

Therapeutic decision support Position decision-support software, real-time monitoring dashboards, and personalized treatment optimization tools that align with Celera’s mission to tailor therapies and monitor effectiveness.

Acquisition and funding signals Note past acquisitions and a revenue range indicating readiness for strategic partnerships or technology licensing deals; approach as potential entry points for co-development, co-marketing, or equity-based collaborations.